Главная Иностранные тендеры и госзакупки Тендеры Германии

Pharmaceutical products (Германия - Тендер #48194766)

Для перевода текста тендера на нужный язык воспользуйтесь приложением:

Страна: Германия (другие тендеры и закупки Германия)
Организатор тендера: BARMER
Номер конкурса: 48194766
Дата публикации: 17-11-2023
Источник тендера: Единая система закупок Европейского союза TED

Продвигайте Вашу продукцию на мировые рынки

Доступ к полной информации по данной закупке закрыт.
Зарегистрируйтесь для получения бесплатных рассылок по новым тендерам и просмотра дополнительной информации.
.

Регистрация

2023111320251101 12:00Body governed by public lawContract noticeSuppliesOpen procedureEuropean UnionSubmission for all lotsLowest priceHealth01B0201

Section I
1. Name and addresses
  BARMER
  Lichtscheider Str. 89
  Wuppertal
  42285
  Germany
  E-mail: rabattvertraege@barmer.de
2. Joint procurement
3. Communication
  The procurement documents are available for unrestricted and full direct access, free of charge, at
  https://beschaffungen.barmer.de/NetServer/
  Additional information can be obtained from the abovementioned addressto the abovementioned address
4. Type of the contracting authority:
  Body governed by public law
5. Main activity:
  Health
Section II
1. Scope of the procurement:
  1. Title:
    
    Arzneimittelrabattverträge mit Beitrittsoption - 0075-RVBEITR.66-2023
    Reference number: 0075-RVBEITR.66-2023
  2. Main CPV code:
    33600000
  3. Type of contract:
    Supplies
  4. Short description:
    
    Die vorliegende Bekanntmachung betrifft nicht die Vergabe eines öffentlichen Auftrages im Sinne der Vergabekoordinierungsrichtlinie (2014/24/EU) bzw. des Kartellrechts. Im Interesse einer möglichst breit angelegten Information der interessierten pharmazeutischen Unternehmer erfolgt diese Bekanntmachung im Supplement zum Amtsblatt der Europäischen Union. Die im Rahmen des vorliegenden Bekanntmachungstextes verwendete Verfahrensbezeichnung "offenes Verfahren" (Ziffer IV.1.1) ist den Vorgaben des Bekanntmachungsformulars geschuldet. Hiermit sowie mit der Nutzung des Mediums "TED" ist keinerlei Unterwerfung unter vergaberechtlicher Regelungen verbunden, deren Geltung kraft Gesetzes bzw. Vergabeverordnungen nicht verpflichtend vorgegeben ist. Es handelt sich um einen Rahmenvertrag mit Beitrittsoption, der sich auf diverse Wirkstoffe bezieht.
  5. Estimated total value:
    Value excluding VAT: 1.00 EUR
  6. Information about lots:
    all lots
2. Description
  1. Title:
    
    Beclometason dipropionat und Formoterol (100_6 Mikrogramm, DOS)
    Lot No: 1
  2. Additional CPV code(s):
    33600000
  3. Place of performance:
    Main site or place of performance:
    bundesweit
  4. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die die Wirkstoffkombination Beclometason dipropionat und Formoterol in der Darreichungsform Dosieraerosol und in der Wirkstärke 100/6 Mikrogramm enthalten.
  5. Award criteria:
  6. Estimated value:
    Value excluding VAT: 1.00 EUR
  7. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  8. Information about the limits on the number of candidates to be invited:
  9. Information about variants:
    Variants will be accepted: no
  10. Information about options:
    Options: no
  11. Information about electronic catalogues:
  12. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  13. Additional information:
  14. Title:
    
    Beclometason dipropionat und Formoterol (200_6 Mikrogramm, DOS)
    Lot No: 2
  15. Additional CPV code(s):
    33600000
  16. Place of performance:
    Main site or place of performance:
    bundesweit
  17. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die die Wirkstoffkombination Beclometason dipropionat und Formoterol in der Darreichungsform Dosieraerosol und in der Wirkstärke 200/6 Mikrogramm enthalten.
  18. Award criteria:
  19. Estimated value:
    Value excluding VAT: 1.00 EUR
  20. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  21. Information about the limits on the number of candidates to be invited:
  22. Information about variants:
    Variants will be accepted: no
  23. Information about options:
    Options: no
  24. Information about electronic catalogues:
  25. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  26. Additional information:
  27. Title:
    
    Beclometason dipropionat und Formoterol (100_6 Mikrogramm, IHP)
    Lot No: 3
  28. Additional CPV code(s):
    33600000
  29. Place of performance:
    Main site or place of performance:
    bundesweit
  30. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die die Wirkstoffkombination Beclometason dipropionat und Formoterol in der Darreichungsform Inhalationspulver und in der Wirkstärke 100/6 Mikrogramm enthalten.
  31. Award criteria:
  32. Estimated value:
    Value excluding VAT: 1.00 EUR
  33. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  34. Information about the limits on the number of candidates to be invited:
  35. Information about variants:
    Variants will be accepted: no
  36. Information about options:
    Options: no
  37. Information about electronic catalogues:
  38. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  39. Additional information:
  40. Title:
    
    Beclometason dipropionat und Formoterol (200_6 Mikrogramm, IHP)
    Lot No: 4
  41. Additional CPV code(s):
    33600000
  42. Place of performance:
    Main site or place of performance:
    bundesweit
  43. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die die Wirkstoffkombination Beclometason dipropionat und Formoterol in der Darreichungsform Inhalationspulver und in der Wirkstärke 200/6 Mikrogramm enthalten.
  44. Award criteria:
  45. Estimated value:
    Value excluding VAT: 1.00 EUR
  46. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  47. Information about the limits on the number of candidates to be invited:
  48. Information about variants:
    Variants will be accepted: no
  49. Information about options:
    Options: no
  50. Information about electronic catalogues:
  51. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  52. Additional information:
  53. Title:
    
    Beclometason dipropionat und Formoterol (INH)
    Lot No: 5
  54. Additional CPV code(s):
    33600000
  55. Place of performance:
    Main site or place of performance:
    bundesweit
  56. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die die Wirkstoffkombination Beclometason dipropionat und Formoterol in der Darreichungsform Inhalat enthalten.
  57. Award criteria:
  58. Estimated value:
    Value excluding VAT: 1.00 EUR
  59. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  60. Information about the limits on the number of candidates to be invited:
  61. Information about variants:
    Variants will be accepted: no
  62. Information about options:
    Options: no
  63. Information about electronic catalogues:
  64. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  65. Additional information:
  66. Title:
    
    Budesonid (DOS)
    Lot No: 6
  67. Additional CPV code(s):
    33600000
  68. Place of performance:
    Main site or place of performance:
    bundesweit
  69. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Budesonid in der Darreichungsform Dosieraerosol enthalten.
  70. Award criteria:
  71. Estimated value:
    Value excluding VAT: 1.00 EUR
  72. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  73. Information about the limits on the number of candidates to be invited:
  74. Information about variants:
    Variants will be accepted: no
  75. Information about options:
    Options: no
  76. Information about electronic catalogues:
  77. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  78. Additional information:
  79. Title:
    
    Ciclosporin (ophthalmologische DRF, EDP)
    Lot No: 7
  80. Additional CPV code(s):
    33600000
  81. Place of performance:
    Main site or place of performance:
    bundesweit
  82. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Ciclosporin in einer ophthalmologischen Darreichungsform in Einzeldosispipetten enthalten.
  83. Award criteria:
  84. Estimated value:
    Value excluding VAT: 1.00 EUR
  85. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  86. Information about the limits on the number of candidates to be invited:
  87. Information about variants:
    Variants will be accepted: no
  88. Information about options:
    Options: no
  89. Information about electronic catalogues:
  90. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  91. Additional information:
  92. Title:
    
    Clonazepam
    Lot No: 8
  93. Additional CPV code(s):
    33600000
  94. Place of performance:
    Main site or place of performance:
    bundesweit
  95. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Clonazepam enthalten.
  96. Award criteria:
  97. Estimated value:
    Value excluding VAT: 1.00 EUR
  98. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  99. Information about the limits on the number of candidates to be invited:
  100. Information about variants:
    Variants will be accepted: no
  101. Information about options:
    Options: no
  102. Information about electronic catalogues:
  103. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  104. Additional information:
  105. Title:
    
    Dalteparin natrium
    Lot No: 9
  106. Additional CPV code(s):
    33600000
  107. Place of performance:
    Main site or place of performance:
    bundesweit
  108. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Dalteparin natrium enthalten.
  109. Award criteria:
  110. Estimated value:
    Value excluding VAT: 1.00 EUR
  111. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  112. Information about the limits on the number of candidates to be invited:
  113. Information about variants:
    Variants will be accepted: no
  114. Information about options:
    Options: no
  115. Information about electronic catalogues:
  116. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  117. Additional information:
  118. Title:
    
    Eletriptan
    Lot No: 10
  119. Additional CPV code(s):
    33600000
  120. Place of performance:
    Main site or place of performance:
    bundesweit
  121. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Eletriptan enthalten.
  122. Award criteria:
  123. Estimated value:
    Value excluding VAT: 1.00 EUR
  124. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  125. Information about the limits on the number of candidates to be invited:
  126. Information about variants:
    Variants will be accepted: no
  127. Information about options:
    Options: no
  128. Information about electronic catalogues:
  129. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  130. Additional information:
  131. Title:
    
    Enoxaparin natrium (N2, 100mg)
    Lot No: 11
  132. Additional CPV code(s):
    33600000
  133. Place of performance:
    Main site or place of performance:
    bundesweit
  134. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Enoxaparin natrium in der Normgröße N2 und der Wirkstärke 100mg enthalten.
  135. Award criteria:
  136. Estimated value:
    Value excluding VAT: 1.00 EUR
  137. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  138. Information about the limits on the number of candidates to be invited:
  139. Information about variants:
    Variants will be accepted: no
  140. Information about options:
    Options: no
  141. Information about electronic catalogues:
  142. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  143. Additional information:
  144. Title:
    
    Epoetin beta
    Lot No: 12
  145. Additional CPV code(s):
    33600000
  146. Place of performance:
    Main site or place of performance:
    bundesweit
  147. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Epoetin beta enthalten.
  148. Award criteria:
  149. Estimated value:
    Value excluding VAT: 1.00 EUR
  150. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  151. Information about the limits on the number of candidates to be invited:
  152. Information about variants:
    Variants will be accepted: no
  153. Information about options:
    Options: no
  154. Information about electronic catalogues:
  155. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  156. Additional information:
  157. Title:
    
    Epoetin zeta
    Lot No: 13
  158. Additional CPV code(s):
    33600000
  159. Place of performance:
    Main site or place of performance:
    bundesweit
  160. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Epoetin zeta enthalten.
  161. Award criteria:
  162. Estimated value:
    Value excluding VAT: 1.00 EUR
  163. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  164. Information about the limits on the number of candidates to be invited:
  165. Information about variants:
    Variants will be accepted: no
  166. Information about options:
    Options: no
  167. Information about electronic catalogues:
  168. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  169. Additional information:
  170. Title:
    
    Follitropin beta
    Lot No: 14
  171. Additional CPV code(s):
    33600000
  172. Place of performance:
    Main site or place of performance:
    bundesweit
  173. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Follitropin beta enthalten.
  174. Award criteria:
  175. Estimated value:
    Value excluding VAT: 1.00 EUR
  176. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  177. Information about the limits on the number of candidates to be invited:
  178. Information about variants:
    Variants will be accepted: no
  179. Information about options:
    Options: no
  180. Information about electronic catalogues:
  181. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  182. Additional information:
  183. Title:
    
    Goserelin
    Lot No: 15
  184. Additional CPV code(s):
    33600000
  185. Place of performance:
    Main site or place of performance:
    bundesweit
  186. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Goserelin enthalten.
  187. Award criteria:
  188. Estimated value:
    Value excluding VAT: 1.00 EUR
  189. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  190. Information about the limits on the number of candidates to be invited:
  191. Information about variants:
    Variants will be accepted: no
  192. Information about options:
    Options: no
  193. Information about electronic catalogues:
  194. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  195. Additional information:
  196. Title:
    
    Granisetron (ILO)
    Lot No: 16
  197. Additional CPV code(s):
    33600000
  198. Place of performance:
    Main site or place of performance:
    bundesweit
  199. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Granisetron in der Darreichungsform ILO enthalten.
  200. Award criteria:
  201. Estimated value:
    Value excluding VAT: 1.00 EUR
  202. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  203. Information about the limits on the number of candidates to be invited:
  204. Information about variants:
    Variants will be accepted: no
  205. Information about options:
    Options: no
  206. Information about electronic catalogues:
  207. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  208. Additional information:
  209. Title:
    
    Granisetron (PFT)
    Lot No: 17
  210. Additional CPV code(s):
    33600000
  211. Place of performance:
    Main site or place of performance:
    bundesweit
  212. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Granisetron in der Darreichungsform Pflaster transdermal enthalten.
  213. Award criteria:
  214. Estimated value:
    Value excluding VAT: 1.00 EUR
  215. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  216. Information about the limits on the number of candidates to be invited:
  217. Information about variants:
    Variants will be accepted: no
  218. Information about options:
    Options: no
  219. Information about electronic catalogues:
  220. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  221. Additional information:
  222. Title:
    
    Immunglobulin G vom Menschen
    Lot No: 18
  223. Additional CPV code(s):
    33600000
  224. Place of performance:
    Main site or place of performance:
    bundesweit
  225. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Immunglobulin G vom Menschen enthalten.
  226. Award criteria:
  227. Estimated value:
    Value excluding VAT: 1.00 EUR
  228. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  229. Information about the limits on the number of candidates to be invited:
  230. Information about variants:
    Variants will be accepted: no
  231. Information about options:
    Options: no
  232. Information about electronic catalogues:
  233. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  234. Additional information:
  235. Title:
    
    Interferon beta-1a (Avonex®)
    Lot No: 19
  236. Additional CPV code(s):
    33600000
  237. Place of performance:
    Main site or place of performance:
    bundesweit
  238. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Interferon beta-1a (Avonex®) enthalten.
  239. Award criteria:
  240. Estimated value:
    Value excluding VAT: 1.00 EUR
  241. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  242. Information about the limits on the number of candidates to be invited:
  243. Information about variants:
    Variants will be accepted: no
  244. Information about options:
    Options: no
  245. Information about electronic catalogues:
  246. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  247. Additional information:
  248. Title:
    
    Natalizumab (intravasal)
    Lot No: 20
  249. Additional CPV code(s):
    33600000
  250. Place of performance:
    Main site or place of performance:
    bundesweit
  251. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Natalizumab in einer intravasalen Darreichungsform enthalten.
  252. Award criteria:
  253. Estimated value:
    Value excluding VAT: 1.00 EUR
  254. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  255. Information about the limits on the number of candidates to be invited:
  256. Information about variants:
    Variants will be accepted: no
  257. Information about options:
    Options: no
  258. Information about electronic catalogues:
  259. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  260. Additional information:
  261. Title:
    
    Natalizumab (subkutan)
    Lot No: 21
  262. Additional CPV code(s):
    33600000
  263. Place of performance:
    Main site or place of performance:
    bundesweit
  264. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Natalizumab in einer subkutanen Darreichungsform enthalten.
  265. Award criteria:
  266. Estimated value:
    Value excluding VAT: 1.00 EUR
  267. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  268. Information about the limits on the number of candidates to be invited:
  269. Information about variants:
    Variants will be accepted: no
  270. Information about options:
    Options: no
  271. Information about electronic catalogues:
  272. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  273. Additional information:
  274. Title:
    
    Paliperidon (DIS)
    Lot No: 22
  275. Additional CPV code(s):
    33600000
  276. Place of performance:
    Main site or place of performance:
    bundesweit
  277. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Paliperidon in der Darreichungsform DIS enthalten.
  278. Award criteria:
  279. Estimated value:
    Value excluding VAT: 1.00 EUR
  280. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  281. Information about the limits on the number of candidates to be invited:
  282. Information about variants:
    Variants will be accepted: no
  283. Information about options:
    Options: no
  284. Information about electronic catalogues:
  285. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  286. Additional information:
  287. Title:
    
    Testosteron
    Lot No: 23
  288. Additional CPV code(s):
    33600000
  289. Place of performance:
    Main site or place of performance:
    bundesweit
  290. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Testosteron enthalten.
  291. Award criteria:
  292. Estimated value:
    Value excluding VAT: 1.00 EUR
  293. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  294. Information about the limits on the number of candidates to be invited:
  295. Information about variants:
    Variants will be accepted: no
  296. Information about options:
    Options: no
  297. Information about electronic catalogues:
  298. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  299. Additional information:
  300. Title:
    
    Tinzaparin natrium
    Lot No: 24
  301. Additional CPV code(s):
    33600000
  302. Place of performance:
    Main site or place of performance:
    bundesweit
  303. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Tinzaparin natrium enthalten.
  304. Award criteria:
  305. Estimated value:
    Value excluding VAT: 1.00 EUR
  306. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  307. Information about the limits on the number of candidates to be invited:
  308. Information about variants:
    Variants will be accepted: no
  309. Information about options:
    Options: no
  310. Information about electronic catalogues:
  311. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  312. Additional information:
  313. Title:
    
    Tobramycin (HPI)
    Lot No: 25
  314. Additional CPV code(s):
    33600000
  315. Place of performance:
    Main site or place of performance:
    bundesweit
  316. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Tobramycin in der Darreichungsform Hartkapsel mit Pulver zur Inhalation enthalten.
  317. Award criteria:
  318. Estimated value:
    Value excluding VAT: 1.00 EUR
  319. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  320. Information about the limits on the number of candidates to be invited:
  321. Information about variants:
    Variants will be accepted: no
  322. Information about options:
    Options: no
  323. Information about electronic catalogues:
  324. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  325. Additional information:
  326. Title:
    
    Tocilizumab (i.v.)
    Lot No: 26
  327. Additional CPV code(s):
    33600000
  328. Place of performance:
    Main site or place of performance:
    bundesweit
  329. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Tocilizumab in einer intravenösen Darreichungsform enthalten.
  330. Award criteria:
  331. Estimated value:
    Value excluding VAT: 1.00 EUR
  332. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  333. Information about the limits on the number of candidates to be invited:
  334. Information about variants:
    Variants will be accepted: no
  335. Information about options:
    Options: no
  336. Information about electronic catalogues:
  337. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  338. Additional information:
  339. Title:
    
    Tocilizumab (subkutan)
    Lot No: 27
  340. Additional CPV code(s):
    33600000
  341. Place of performance:
    Main site or place of performance:
    bundesweit
  342. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Tocilizumab in einer subkutanen Darreichungsform enthalten.
  343. Award criteria:
  344. Estimated value:
    Value excluding VAT: 1.00 EUR
  345. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  346. Information about the limits on the number of candidates to be invited:
  347. Information about variants:
    Variants will be accepted: no
  348. Information about options:
    Options: no
  349. Information about electronic catalogues:
  350. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  351. Additional information:
  352. Title:
    
    Triamcinolon acetonid (D07AB09)
    Lot No: 28
  353. Additional CPV code(s):
    33600000
  354. Place of performance:
    Main site or place of performance:
    bundesweit
  355. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Triamcinolon acetonid mit dem ATC Code D07AB09 enthalten.
  356. Award criteria:
  357. Estimated value:
  358. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  359. Information about the limits on the number of candidates to be invited:
  360. Information about variants:
    Variants will be accepted: no
  361. Information about options:
    Options: no
  362. Information about electronic catalogues:
  363. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  364. Additional information:
  365. Title:
    
    Trientin
    Lot No: 29
  366. Additional CPV code(s):
    33600000
  367. Place of performance:
    Main site or place of performance:
    bundesweit
  368. Description of the procurement:
    
    Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Trientin enthalten.
  369. Award criteria:
  370. Estimated value:
    Value excluding VAT: 1.00 EUR
  371. Duration of the contract, framework agreement or dynamic purchasing system:
    
    Start: 2024-01-01
    End: 2025-12-31
    This contract is subject to renewal: yes
    Description of renewals:
    Einmalige Verlängerungsoption um drei Monate bis 31.03.2026.
  372. Information about the limits on the number of candidates to be invited:
  373. Information about variants:
    Variants will be accepted: no
  374. Information about options:
    Options: no
  375. Information about electronic catalogues:
  376. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  377. Additional information:
Section III
1. Conditions for participation:
  1. Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers:
    List and brief description of conditions:
    Vervollständigte und unterschriebene Eigenerklärung (Anlage E1) zur Zuverlässigkeit.
  2. Economic and financial standing:
  3. Technical and professional ability:
  4. Information about reserved contracts:
2. Conditions related to the contract:
  1. Information about a particular profession:
  2. Information about staff responsible for the performance of the contract:
Section IV
Description:
1. Type of procedure:
  Open procedure
2. Information about a framework agreement or a dynamic purchasing system:
  Framework agreement with several operators
3. Information about reduction of the number of solutions or tenders during negotiation or dialogue:
4. Information about negotiation:
5. Information about electronic auction:
6. Information about the Government Procurement Agreement (GPA):
  The procurement is covered by the Government Procurement Agreement: no
Administrative information:
1. Previous publication concerning this procedure:
2. Time limit for receipt of tenders or requests to participate:
  Date: 2025-11-01
  Local time: 12:00
3. Estimated date of dispatch of invitations to tender or to participate to selected candidates:
4. Languages in which tenders or requests to participate may be submitted:
  DE
5. Minimum time frame during which the tenderer must maintain the tender:
  Tender must be valid until: 2026-03-31
  (from the date stated for receipt of tender)
6. Conditions for opening of tenders:
  Date: 2025-11-02
  Local time: 13:00

Section VI

Information about recurrence
This is a recurrent procurement: no
Information about electronic workflows
Additional information
Procedures for review
1. Review body
  Vergabekammer des Bundes beim Bundeskartellamt Bonn
  Villemombler Str. 76
  Bonn
  53123
  Germany
  Contact person: 53123
2. Body responsible for mediation procedures
3. Review procedure
  Precise information on deadline(s) for review procedures:
  Ein Nachprüfungsantrag kann bei der Vergabekammer des Bundes, Bundeskartellamt Bonn,VillemomblerStraße 76, 53123 Bonn, gestellt werden. Der Antrag ist unzulässig, soweit: 1. der Antragsteller den geltend gemachten Verstoß gegen Vergabevorschriften vor Einreichen des Nachprüfungsantrags erkannt und gegenüber dem Auftraggeber nicht innerhalb einer Frist von 10Kalendertagen gerügt hat; der Ablauf der Frist nach § 134 Absatz 2 GWB bleibt unberührt, 2. Verstöße gegen Vergabevorschriften, die aufgrund der Bekanntmachung erkennbar sind, nicht spätestens bis zum Ablauf der in der Bekanntmachung benannten Frist zur Bewerbung oder zur Angebotsabgabe gegenüber dem Auftraggeber gerügt werden, 3. Verstöße gegen Vergabevorschriften, die erst in den Vergabeunterlagen erkennbar sind, nicht spätestens bis zum Ablauf der Frist zur Bewerbung oder zur Angebotsabgabe gegenüber dem Auftraggeber gerügt werden, 4. mehr als 15 Kalendertage nach Eingang der Mitteilung des Auftraggebers, einer Rüge nicht abhelfen zu wollen, vergangen sind. Satz 1 gilt nicht bei einem Antrag auf Feststellung der Unwirksamkeit des Vertrags nach § 135 Absatz 1 Nummer2 GWB. § 134 Absatz 1 Satz 2 GWB bleibt unberührt.
4. Service from which information about the review procedure may be obtained
  
  Ein Nachprüfungsantrag kann bei der Vergabekammer des Bundes, Bundeskartellamt Bonn,VillemomblerStraße 76, 53123 Bonn, gestellt werden. Der Antrag ist unzulässig, soweit: 1. der Antragsteller den geltend gemachten Verstoß gegen Vergabevorschriften vor Einreichen des Nachprüfungsantrags erkannt und gegenüber dem Auftraggeber nicht innerhalb einer Frist von 10Kalendertagen gerügt hat; der Ablauf der Frist nach § 134 Absatz 2 GWB bleibt unberührt, 2. Verstöße gegen Vergabevorschriften, die aufgrund der Bekanntmachung erkennbar sind, nicht spätestens bis zum Ablauf der in der Bekanntmachung benannten Frist zur Bewerbung oder zur Angebotsabgabe gegenüber dem Auftraggeber gerügt werden, 3. Verstöße gegen Vergabevorschriften, die erst in den Vergabeunterlagen erkennbar sind, nicht spätestens bis zum Ablauf der Frist zur Bewerbung oder zur Angebotsabgabe gegenüber dem Auftraggeber gerügt werden, 4. mehr als 15 Kalendertage nach Eingang der Mitteilung des Auftraggebers, einer Rüge nicht abhelfen zu wollen, vergangen sind. Satz 1 gilt nicht bei einem Antrag auf Feststellung der Unwirksamkeit des Vertrags nach § 135 Absatz 1 Nummer2 GWB. § 134 Absatz 1 Satz 2 GWB bleibt unberührt.
Date of dispatch of this notice
2023-11-13

Источник закупки

Перейти

Импорт - Экспорт по стране Германия

Кроме мониторинга зарубежных тендеров для ведения успешного бизнеса изучите информацию о стране: какая продукция экспортируется и импортируется и на какие суммы. Определите коды ТН ВЭД интересующей вас продукции.

Экспорт Импорт

Еще тендеры и закупки за эти даты

17-11-2023 Software package and information systems.

17-11-2023 Software package and information systems.

17-11-2023 Software package and information systems.

17-11-2023 Special-purpose road passenger-transport services.

17-11-2023 Supervision of building work.

17-11-2023 Accounting and auditing services.

Copyright © 2008-2026, TenderGURU
Все права защищены. Полное или частичное копирование запрещено.
При согласованном использовании материалов сайта TenderGURU.ru необходима гиперссылка на ресурс.
Электронная почта: info@tenderguru.ru
Многоканальный телефон 8-800-555-89-39
с любого телефона из любого региона для Вас звонок бесплатный!

Портал отображает информацию о закупках, публикуемых в сети интернет
и находящихся в открытом доступе, и предназначен для юрлиц и индивидуальных предпринимателей,
являющихся участниками размещения государственного и коммерческого заказа. Сайт использует Cookie, которые нужны для авторизации пользователя.
На сайте стоят счетчики Яндекс.Метрика, Google Analytics и LiveInternet,
которые нужны для статистики посещения ресурса.

Политика обработки персональных данных tenderguru.ru